SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017O_1: Single- and multiple-ascending doses (SAD/MAD) and food effect of orally administered JNJ-64155806 in healthy volunteers- Thomas Kakuda, PharmDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017Current and Future Treatment of CMV- Robin Avery, MDView Slideset
SlidesetHIVBrazilian HIV Clinical Forum 2017Clinical Case on Integrase Inhibitors Use in TB-Infected Patients- Dr. L. GrinsztejnView Slideset
SlidesetHIVBrazilian HIV Clinical Forum 2017HIV Integrase Inhibitors in an Aging Population (Polypharmacy - Comorbidities)- Dr. M.C.Rachid de LacerdaView Slideset
RERichard ElionMDSlidesetHIVBrazilian HIV Clinical Forum 2017The Role of HIV Integrase Inhibitors in PrEP & PEP- Richard ElionView Slideset
SlidesetHIVBrazilian HIV Clinical Forum 2017Clinical Case Discussion 3- Dr. M.C.Rachid de LacerdaView Slideset
RDRicardo DiazMDSlidesetHIVBrazilian HIV Clinical Forum 2017Is Baseline Resistance Testing Needed?- Ricardo Diaz, MDView Slideset
SlidesetHIVBrazilian HIV Clinical Forum 2017Clinical Case Discussion 1- Dr. T.R. Constant VergaraView Slideset
IGIshwar GiladaMD, DDV, FCPSVideoHIVAsia-Pacific HIV Clinical Forum 2017Clinical case presentation | Ishwar Gilada, MD, DDV, FCPSView Video
CBCharles BoucherMD, PhDVideoHIVAsia-Pacific HIV Clinical Forum 2017HIV Macroprevention, epidemiology, phylogenics and networks | Charles Boucher, MD, PhDView Video
DKDaniel KuritzkesMDVideoHIVAsia-Pacific HIV Clinical Forum 2017Understanding Viral Suppression | Daniel Kuritzkes, MDView Video
